Health and Fitness Health and Fitness
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
Alexion to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Medivation Announces Participation at Three Upcoming Investor Conferences
[ Wed, Nov 23rd 2011 ] - Market Wire
Micromet to Present at the 2011 Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
HealthSouth to Present at Bank of America Merrill Lynch Leveraged Finance Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Regeneron Announces Upcoming Investor Conference Presentations
[ Wed, Nov 23rd 2011 ] - Market Wire
Aetna, McDermott International, Kellogg, General Mills and Ralcorp Holdings
[ Wed, Nov 23rd 2011 ] - Market Wire
Antares Pharma, Inc., Global Cash Access Holdings .. , Raptor Pharmaceuticals Corp. and TASER Internat
[ Wed, Nov 23rd 2011 ] - Market Wire
First Patient Dosed in Cervical Region in Neuralstem ALS Stem Cell Trial
[ Wed, Nov 23rd 2011 ] - Market Wire
Smart-Tek Solutions, Inc. Expects to Recapture Revenue by Next Quarter
[ Wed, Nov 23rd 2011 ] - Market Wire
A Change in Tides - Featured Research on Medtronic, Inc. and St. Jude Medical, Inc.
[ Wed, Nov 23rd 2011 ] - Market Wire
Endo Pharmaceuticals to Present at the Bank of Am .. a Merrill Lynch 2011 Leveraged Finance Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Dynavax and Vical -- Undervalued and Gaining Attention
[ Wed, Nov 23rd 2011 ] - Market Wire
AcelRx Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Aeterna Zentaris and Hikma Pharmaceuticals Sign a .. ing Agreement for Lead Oncology Compound, Perifos
[ Wed, Nov 23rd 2011 ] - Market Wire
Covidien to Present at Piper Jaffray Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Arrowhead Research Appoints Drs. David Lewis and .. Rozema to Lead Operations at Madison, WI Facility
[ Wed, Nov 23rd 2011 ] - Market Wire
Isis Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
PAREXEL Strengthens Late Phase and Observational .. pert Team to Help Biopharma Meet Commercializatio
[ Wed, Nov 23rd 2011 ] - Market Wire
HeartWare to Present at the 23rd Annual Piper Jaffray Health Care Conference
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
Gilead Sciences koopt Pharmasset, Inc. voor $11 miljard
[ Tue, Nov 22nd 2011 ] - Market Wire
Gilead Sciences wird Pharmasset, Inc. fr 11 Milliarden US-Dollar bernehmen
[ Tue, Nov 22nd 2011 ] - Market Wire
Gilead Sciences sta per acquisire Pharmasset, Inc., per 11 miliardi di dollari
[ Tue, Nov 22nd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. ssible Securities Laws Violations by Chemed Corp.
[ Tue, Nov 22nd 2011 ] - Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in Hospira, Inc. of Class Actio
[ Tue, Nov 22nd 2011 ] - Market Wire
Izard Nobel LLP Announces Class Action Lawsuit Against Hospira, Inc.
[ Tue, Nov 22nd 2011 ] - Market Wire
Commencement of Share Repurchase Programme
[ Tue, Nov 22nd 2011 ] - Market Wire
AVI BioPharma to Present Company Overview at the Piper Jaffray Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Celgene Will Discontinue Phase III MAINSAIL Trial in Castrate-Resistant Prostate Cancer
[ Tue, Nov 22nd 2011 ] - Market Wire
Dendreon Announces Webcast Presentation at Upcoming Conferences
[ Tue, Nov 22nd 2011 ] - Market Wire
AMAG Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Healthcare Conference

AMAG Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Healthcare Conference


Published on 2011-11-22 13:40:49 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the 23rd Annual Piper Jaffray Healthcare Conference on November 29 at 2:30 pm ET in New York City. Company management will provide a brief overview of the company followed by a question and answer period with investors.

A live webcast of each presentation will be accessible through the Investors section of the companyas website at [ www.amagpharma.com ]. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit [ www.amagpharma.com ].

Contributing Sources